000 01887 a2200553 4500
005 20250516014606.0
264 0 _c20110325
008 201103s 0 0 eng d
022 _a1744-8042
024 7 _a10.2217/pgs.10.132
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMichelon, Hugues
245 0 0 _aSLCO1B1 genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients.
_h[electronic resource]
260 _bPharmacogenomics
_cDec 2010
300 _a1703-13 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aBiotransformation
_xgenetics
650 0 4 _aCell Line
650 0 4 _aDNA
_xgenetics
650 0 4 _aFemale
650 0 4 _aGraft Rejection
_xgenetics
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xadministration & dosage
650 0 4 _aKidney Transplantation
650 0 4 _aLeukocytes
_xmetabolism
650 0 4 _aLiver-Specific Organic Anion Transporter 1
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMultidrug Resistance-Associated Protein 2
650 0 4 _aMycophenolic Acid
_xadministration & dosage
650 0 4 _aOrganic Anion Transporters
_xgenetics
650 0 4 _aPolymerase Chain Reaction
650 0 4 _aPolymorphism, Single Nucleotide
650 0 4 _aRetrospective Studies
650 0 4 _aSubstrate Specificity
650 0 4 _aTransfection
700 1 _aKönig, Jörg
700 1 _aDurrbach, Antoine
700 1 _aQuteineh, Lina
700 1 _aVerstuyft, Céline
700 1 _aFurlan, Valérie
700 1 _aFerlicot, Sophie
700 1 _aLetierce, Alexia
700 1 _aCharpentier, Bernard
700 1 _aFromm, Martin F
700 1 _aBecquemont, Laurent
773 0 _tPharmacogenomics
_gvol. 11
_gno. 12
_gp. 1703-13
856 4 0 _uhttps://doi.org/10.2217/pgs.10.132
_zAvailable from publisher's website
999 _c20433385
_d20433385